The IMBA project-team (Programme Group Humans, Environment, Technology of the Jülich Research Centre and the Working Group Bioethics and Science Communication of the Max Delbrueck Center for Molecular Medicine (MDC)) is  hosting this Meeting to discuss the promises of new omics technologies for risk assessment. Much progress has been made in recent years in the development of new techniques in the genomics, transcriptomics, proteomics as well as metabolomics field. The aim of the workshop is not to present special data from a special field but to bring together people from different fields and to extensively discuss challenges and promises of future omics technologies for risk assessment and especially for EMF cancer risk assessment.

We look forward to welcoming you in Berlin, the beautiful capital of Germany in the early summer of 2008.

The workshop promises to become an exciting scientific meeting: register now if you like to participate.
Or just subscribe our newsletter and we will keep you informed about any upcoming news.